Kong N C, Morad Z, Suleiman A B
Singapore Med J. 1989 Jun;30(3):261-2.
We reviewed our experience with subclavian vascular catheters (SVC) as temporary vascular access in the 18 month period 1 January 1984-30 June 1985. 37 consecutive patients using 49 vascular catheters received a total of 461 haemodialyses. Only 8 patients had acute renal failure. The rest were endstage renal failure (ESRF) patients awaiting definitive vascular access. Most of these latter patients were ambulant and were generally dialysed on an outpatient basis. 27 episodes of clinical septicaemia occurred and was the ONLY significant complication encountered. All but one patient responded to empiric therapy with cloxacillin +/- gentamicin and removal of the catheter. We conclude that SVC's are safe and suitable for use on an extended short-term basis especially in ESRF patients with vascular access problems.
我们回顾了1984年1月1日至1985年6月30日这18个月期间,将锁骨下血管导管(SVC)作为临时血管通路的经验。37例连续患者使用了49根血管导管,总共进行了461次血液透析。只有8例患者患有急性肾衰竭。其余患者均为终末期肾衰竭(ESRF)患者,正在等待确定的血管通路。这些后期患者中的大多数可以走动,通常在门诊进行透析。发生了27次临床败血症发作,这是唯一遇到的重大并发症。除1例患者外,所有患者均对氯唑西林+/-庆大霉素的经验性治疗及拔除导管有反应。我们得出结论,SVC在延长的短期使用中是安全且合适的,尤其是对于有血管通路问题的ESRF患者。